Ligand logo

LigandLGND

NASDAQ

Pharmaceuticals

$277.00-1.26%

No cached AI snapshot yet for LGND.

Be the first to run a multi-agent analysis on this ticker.

Key Stats

$4.52BMarket cap
$247.3852-week high
$98.8952-week low
226,822Avg volume (30d)

47 employees19.94M shares outstandinglisted 1994-11-25

Next earnings ~May 5, 2026 · Ex-dividend Jul 2, 2010 · Dividend $0.08 irregular

About Ligand

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Latest News

Showing market-wide stock news

Related Stocksin Pharmaceuticals

Ready to see the live AI view on LGND?

Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing LGND side-by-side with live signals.